Evidence map›Paper›PMID 41107722›Full record

ArticleBMC microbiology2025

Characterization and transmission dynamics of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae isolated from eight teaching hospitals in Guangdong province, China (2022-2024).

Guanqing Chen, Xinliang Yan, Yinghao Zhou, Junlin Feng, Chunqing Bai, Ruiying Li, Haiyan Cui, Yujie Jiang, Haitao Chen, Danxia Bu and 2 more

Abstract read
In one paragraph

Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Genomic Epidemiology of NDM-1 Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guanqing Chen *Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Xinliang Yan *Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Yinghao ZhouDepartmentof Clinical Laboratory, The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Junlin FengLaboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Chunqing BaiLaboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Ruiying LiDepartment of Clinical Laboratory, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510030, China.
Haiyan CuiDepartment of Clinical Laboratory, Longgang District People's Hospital, Shenzhen, Guangdong, 518172, China.
Yujie JiangDepartment of Clinical Laboratory, Guangdong Agricultural Reclamation Central Hospital, Zhanjiang, Guangdong, 524001, China.
Haitao ChenDepartment of Clinical Laboratory, Lianjiang People' s Hospital, Lianjiang, Guangdong, 524400, China.
Danxia BuDepartment of Clinical Laboratory, Zhanjiang Central Hospital, Guangdong Medical University (Central People's Hospital of Zhanjiang), Zhanjiang, Guangdong, 524023, China.
Mufa CaiLaboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Jun LiuLaboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524023, China. lj2388240@gdmu.edu.cn.

Funding

Funds for PHD researchers of Guangdong Medical University in 2020 No.GDMUB2020009The Characteristic Innovation Project of Colleges and Universities in Guangdong Province No. 2020KTSCX041The Finance Special Project of Zhanjiang City No.2021A05095The general project of Guangdong Medical Science and Technology Research Foundation No.A2021207
6 · The paper itself

Abstract

backgroundThe Corona Virus Disease 2019 (COVID-19) pandemic has introduced complex challenges in resistance and transmission. During the COVID-19 pandemic, increased antibiotic use, interruptions in healthcare services, and complex infections in patients can all promote the emergence and spread of drug-resistant bacteria. However, detailed investigations into the characteristics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) and the alterations in their transmission dynamics during the pandemic remain scarce. This study analyzed 54 CREC strains collected from eight teaching hospitals in Guangdong Province, China, between December 2022 and June 2024.

resultsThe variable temperature Sodium Dodecyl Sulfate (SDS) plasmid elimination method and PCR were used to analyze the samples. The positive rate of CEGs was 85.19% (46/54). Among the 54 CREC isolates, 33.33% (18/54) carried the blaNDM−1 gene on both chromosomes and plasmids. A total of 46.30% (25/54) of the isolates had the blaNDM−1 gene exclusively on plasmids. Additionally, 3.70% (2/54) of the isolates harbored only the blaIMP gene on plasmids. Finally, 1.85% (1/54) of the isolates contained both the blaNDM−1 gene and blaKPC−2 gene on plasmids. The broth microdilution method showed that the resistance rate of CEG-positive group to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin and levofloxacin were significantly higher than those of CEG-Negative group (P<0.05). Plasmid conjugation experiments and PCR analysis revealed a 95.65% (44/46) success rate for the transfer of CEGs. Among these, the success rates for the blaNDM−1, blaIMP, and blaKPC−2 genes were 95.45% (42/44), 100.00% (2/2) and 0% (0/1) respectively. Six types of mobile genetic elements were identified, with ISEcp1 being the most prevalent (87.04%, 47/54). CREC carrying four types of mobile genetic elements simultaneously was the most prevalent (40.74%, 22/54). ERIC-PCR and NTSYS software categorized the 54 CREC strains into 17 genotypes, with type E and type G showing the highest prevalence (both of them 20.37%, 11/54), originating from different departments in five hospitals. Among the type E isolates, 3.70% (2/54) strains shared a Dice coefficient of 100%. The epidemiology of CEG shows that the detection rates of men, elderly people, respiratory medicine, and sputum samples are the highest in gender, age group, clinical department, and specimen category, accounting for 64.81% (35/54), 72.22% (39/54), 20.37% (11/54) and 33.33% (18/54), respectively.

conclusionsCREC plasmids and chromosomes frequently harbor CEGs, with the blaNDM−1 gene being a predominant example, particularly when located on plasmids. CEG-positive strains demonstrated significant levels of multidrug resistance. Furthermore, CEGs displayed a notable capacity for both horizontal and vertical dissemination. Higher detection frequencies of CEGs were identified in male patients, elderly individuals, within respiratory medicine contexts, and in sputum samples.

Indexed as

Bacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeEnterobacter cloacaeEnterobacteriaceae InfectionsAnti-Bacterial AgentsCarbapenemsChinaCOVID-19Hospitals, TeachingHumansMicrobial Sensitivity TestsPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsCarbapenemase-encoding geneCarbapenem-resistant Enterobacter cloacaeGuangdong province ChinaTertiary hospitalsTransmission

Identifiers

PMID41107722
PMCPMC12534918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.